DOVER, N.H.--(BUSINESS WIRE)--TissueLink Medical Inc., a privately held medical device company, announced today the retirement of company co-founder M. Jacqueline Eastwood and separately, the appointment of Joseph F. Army as President and Chief Executive Officer of the company, effective June 16, 2007.
In commenting on her retirement and Mr. Army’s appointment as CEO, Ms. Eastwood said “I am ready to focus on other things that I have started including a school for street children in Cambodia. The business is strong, the Aquamantys(TM) System is gaining rapid market acceptance, and I have great confidence in Joe’s ability to lead the company through this period of rapid growth.”
Mr. Army joined TissueLink in 1999 as Chief Financial Officer. Prior to joining TissueLink, Mr. Army had been Vice President of Finance and Supply Chain Operations for Westaim Biomedical Corp., a startup focused on infection control. Previously Mr. Army worked at Coopers & Lybrand Consulting from 1991 to 1997, ultimately serving as Director of its strategy consulting practice in the firm’s Philadelphia office. He holds a BA in history from the University of Rhode Island and an MBA from The Wharton School of Business of the University of Pennsylvania.
About TissueLink Medical, Inc.
TissueLink Medical, founded in 1999, is a private company that develops and markets innovative disposable surgical devices that reduce or eliminate bleeding in surgery. Over 100,000 patients worldwide have benefited from the company’s products. TissueLink technology is used by surgeons to control bleeding in solid organ resections, orthopaedic reconstruction and spine surgery. The company’s proprietary technology can apply to multiple surgical specialties addressing markets that exceed $3.5 billion.
For more information on TissueLink Medical, visit the company website at www.tissuelink.com.
Contact: John Landry Controller TissueLink Medical, Inc. 800-354-2808 (toll-free) 603-742-1515 (direct)
Source: TissueLink Medical Inc.
